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OBJECTIVE: The aim of this study was to evaluate the roles of the Taql and Bsml vitamin D receptor gene
polymorphisms in hospital mortality of burn patients.
METHODS: In total, 105 consecutive burn injury patients over 18 years in age who were admitted to the Burn
Unit of Bauru State Hospital from January to December 2013 were prospectively evaluated. Upon admission,
patient demographic information was recorded and a blood sample was taken for biochemical analysis to
identify the presence of the Taql(rs731236) and Bsml(rs1544410) polymorphisms. All of the patients were
followed over their hospital stay and mortality was recorded.
RESULTS: Eighteen of the patients did not sign the informed consent form, and there were technical problems
with genotype analysis for 7 of the patients. Thus, 80 patients (mean age, 42.5±16.1 years) were included in the
final analysis. In total, 60% of the patients were male, and 16.3% died during the hospital stay. The genotype
frequencies for the Taql polymorphism were 51.25% TT, 41.25% TC and 7.50% CC; for the Bsml polymorphism,
they were 51.25% GG, 42.50% GA and 6.25% AA. In logistic regression analysis, after adjustments for age,
gender and total body surface burn area, there were no associations between the Taql (OR: 1.575; CI95%: 0.148-
16.745; p=0.706) or Bsml (OR: 1.309; CI95%: 0.128-13.430; p=0.821) polymorphisms and mortality for the burn
patients.
CONCLUSIONS: Our results suggest that the Taql and Bsml vitamin D receptor gene polymorphisms are not
associated with hospital mortality of burn patients.
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’ INTRODUCTION
Burn injury is a type of traumatic injury that is associated
with considerable morbidity and mortality (1). Burn injury is
the fourth most common cause of severe injury following
road accidents, falls and violence (1-2). In a systematic
review, Brusselaers et al. reported that the mortality rate for
burn injury ranged between 1.4 and 18%, and the major
causes of death were multiple organ failure and sepsis (3).
Thus, augmented systemic inflammatory responses are
associated with burn patient mortality (4). To modulate the
inflammatory process induced by burn injury, micronutrient
supplementation, including with vitamin D, is one proposed
intervention.
Vitamin D is a prohormone with a key role in balancing
calcium and phosphate levels and is important for bone
structure. In the last decade, the importance of vitamin D in
the immune response and for inflammatory processes has
been addressed. In addition, observational studies have
shown an association between vitamin D deficiency and
mortality in critically ill patients (5-6). Studies on vitamin D
supplementation in burn patients have produced contra-
dictory results, and whether all patients would benefit from
vitamin D supplementation is unknown (7). The action of
vitamin D occurs predominantly through its interaction with
the vitamin D receptor (VDR). Recently, polymorphisms in
the VDR gene, such as the Taql and Bsml polymorphisms,
have been identified. The presence of the recessive alleles of
Taql and Bsml has been associated with the prognoses of
acute and chronic inflammatory diseases and could influence
individual responses to vitamin D supplementation (8,9).
The influence of the Taql and Bsml VDR gene polymorph-
isms on the mortality of burn patients has not been
evaluated. Thus, the aim of this study was to evaluate the
roles of the Taql and Bsml VDR gene polymorphisms in the
hospital mortality of burn patients.DOI: 10.6061/clinics/2016(08)10
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’ MATERIALS AND METHODS
This study was approved by the Ethics Committee of
Botucatu Medical School and was conducted in accordance
with the Helsinki Declaration of 1975, which was revised
in 1983. Written informed consent was obtained from all
the patients. Burn injury patients over 18 years of age who
were admitted to the Burn Unit of Bauru State Hospital
from January to December 2013 were prospectively eval-
uated. The sample size was estimated using the following
variables: 20% of the mortality risk for burn patients with a
95% confidence interval and a 10% sampling error (3). The
minimum sample size required was 62 patients.
Upon admission, patient demographic information was
recorded and a blood sample was obtained for biochemical
analysis to identify the presence of the Taql and Bsml
polymorphisms. All of the patients were followed during
their hospital stay and the mortality rate was recorded.
Laboratory data analysis
Total serum levels of sodium, potassium, albumin,
creatinine and urea were measured using a dry chemistry
method (Ortho-Clinical Diagnostics VITROS 950s, Johnson
& Johnson). A hemogram was obtained with a Coulter STKS
hematological autoanalyzer.
Identification of VDR gene polymorphisms
DNAwas isolated from frozen blood samples. Polymerase
chain reaction (PCR) primers corresponding to the sequences
flanking the Taql (rs731236) and Bsml (rs1544410) poly-
morphisms in the human vitamin D receptor gene were
used. PCR was performed following a previously described
method (10).
Statistical analysis
Data are expressed as the mean±SD or the median
(including the lower and upper quartiles). Statistical com-
parisons between groups for continuous variables were
performed using Student’s t-test for parameters with a
normal distribution. If the data were not normally distrib-
uted, comparisons between groups were performed using
the Mann-Whitney test. Fisher’s test or the w2 test was used
for categorical data. Logistic regression models were
adjusted for age, gender and total body surface area (TBSA)
of each burn. Data analysis was performed using SigmaPlot
software for Windows v12.0 (Systat Software, Inc., San Jose,
CA, USA). The significance level was 5%.
’ RESULTS
One-hundred and five consecutive patients were evalu-
ated. Of these, 18 patients did not sign the informed consent
form, and there were technical problems during genotype
analysis for 7 patients. Thus, 80 patients (mean age, 42.5±
16.1 years) were included in the final analysis. Among these
patients, 60% were male and 16.3% died during the hospital
stay. The majority of the patients (47.5%) had burn injuries
resulting from flame exposure. The median TBSA of the
burns was 8.0% (3.0-18.8) and 47.5% of the patients were
admitted to the intensive care unit.
Demographic, clinical and laboratory data according to
hospital mortality are listed in Table 1. The patients who
died while in the hospital were older, had higher burn
TBSAs, were admitted to the intensive care unit (ICU) and
had more full-thickness burns (FTBs). In addition, the
patients who died had lower levels of albumin; higher white
blood cell counts; and higher sodium, creatinine and urea
levels. The genotype frequencies for the Taql polymorphism
Table 1 - Demographic, clinical and laboratory data for 80 patients with burn injury according to hospital mortality.
Variables Hospital mortality p-value
Yes (n=13) No (n=67)
Age (yrs.) 50.0 (37.0 – 62.5) 39.0 (29.0 – 49.0) 0.033
Male, % (no) 46.2 (6) 62.7 (42) 0.421
Etiology, % (n)
Flame 100.0 (13) 37.3 (25) o0.001
Scald 0 (0) 40.3 (27)
Electricity 0 (0) 17.9 (12)
Others 0 (0) 4.5 (3)
TBSA burn, % 38.5 (29.3-52.0) 6.5 (3.0-12.0) o 0.001
FTB, % (n) 92.3 (12) 44.8 (30) 0.005
ICU admission, % (n) 100.0 (13) 37.3 (25) o0.001
Hematocrit, (%) 39.4 (32.2-46.4) 38.5 (35.8-41.7) 0.461
WBC count, (x 103/mL) 20680 (13510-25548) 7695 (6315-10823) o 0.001
Creatinine, (mg/dL) 0.9 (0.8-1.6) 0.8 (0.7-0.9) 0.019
Urea, (mg/dL) 49.0 (33.5-62.0) 29.0 (21.0-36.0) 0.002
Sodium, (mmol/L) 136 (135-142) 135 (134-136) 0.010
Potassium, (mmol/L) 4.3 (3.6-4.8) 3.8 (3.4-4.3) 0.191
Albumin, (g/L) 2.6 (1.9-3.6) 3,4 (3.0-3.7) 0.012
Taql, % (n)
TT 30.8 (4) 55.2 (37) 0.244
TC 61.5 (8) 37.3 (25)
CC 7.7 (1) 7.5 (5)
Bsml, % (n)
GG 38.5 (5) 53.7 (36)
GA 53.8 (7) 40.3 (27)
AA 7.7 (1) 6.0 (4) 0.601
TBSA: Total body surface area (TBSA), FTB: full-thickness burn; ICU: intensive care unit; WBC: white blood cells. The data are expressed as medians
(including the lower and upper quartiles) and proportions.
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were 51.25% TT, 41.25% TC and 7.50% CC; for the Bsml
polymorphism, they were 51.25% GG, 42.50% GA and 6.25%
AA. These frequencies are consistent with those expected
under the Hardy-Weinberg equilibrium. In uni- and multi-
variate analyses, which were adjusted for age, gender and
TBSA, there were no associations between the Taql (TC+CC)
(OR: 1.575; 95%CI: 0.148-16.745; p=0.706) and Bsml
(GA+AA) (OR: 1.309; 95%CI: 0.128-13.430; p=0.821) poly-
morphisms and mortality in the burn patients (Table 2).
’ DISCUSSION
The aim of this study was to evaluate the role of the Taql
and Bsml VDR gene polymorphisms in the hospital mortality
of burn patients. Despite the potential role of the VDR in
systemic inflammation, our results suggest that these VDR
gene polymorphisms are not associated with the hospital
mortality of burn patients.
Brusselaers et al. (3) showed that the mortality rate of
hospitalized patients with severe burn injuries in Europe
ranges between 1.4 and 18%. In the present study, we
calculated a mortality rate of 16.3% during hospital stay,
which is in accordance with Brusselaers’ results. In addition,
the three major risk factors for mortality were older age,
increased TBSA and inhalation injury. The identification of
risk factors for mortality is critical because it enables the
identification of patients who might benefit from specific and
aggressive interventions. In a recent multicenter prospective
cohort study with 573 patients (347 adults), Jeschke et al. (11)
showed that adults with over 40% TBSA are at high risk for
morbidity and mortality. In our study, as expected, the
patients who died were older, had higher burn TBSAs, more
FTBs, worse kidney function and lower albumin levels.
Aguayo-Becerra et al. (12) showed that burn patients with
albumin levels lower than 2 g/dL have a mortality risk
higher than 80%. Another variable that could influence burn
patient mortality is vitamin D deficiency. However, the role
of vitamin D deficiency in this scenario is not completely
understood and vitamin D supplementation in burn patients
has produced contradictory results.
Vitamin D deficiency is estimated to affect more than
1 billion people worldwide. The prevalence of vitamin D
deficiency in burn patients is also high. Gottschlich et al. (13)
showed that 45% of a study population composed of
children with acute burn injuries with higher than 25% TBSAs
had low values of 25-OH vitamin D. In addition, vitamin D
deficiency could also occur and interfere with morbidity in
chronic responses to burn injury. In post-burn scar tissue and
adjacent normal skin, levels of 7-dehydrocholesterol are
decreased, along with its conversion to cholecalciferol (14).
In addition, burn patients are advised to avoid sun exposure to
minimize scar hyperpigmentation (14). Vitamin D deficiency
and upregulation of the parathyroid calcium-sensing receptor
in the chronic phase of burn injury is associated with reduced
bone formation and resorption, as well as osteopenia,
hypocalcemia and hypoparathyroidism (15,16).
The classical actions of vitamin D include its roles in
intestinal calcium absorption, bone resorption and calcium
reabsorption at distal renal tubules in the presence of
parathormone (17). Beyond these known effects, studies
have also demonstrated associations between vitamin D
deficiency and all-cause mortality (5,6). In 135 critically ill
patients, Moraes et al. (6) showed that vitamin D levels lower
than 12 ng/mL on ICU admission were associated with
increased mortality.
Studies of vitamin D supplementation in burn patients
have produced contradictory results (18-20). In adults with
severe burns, Rosseau et al. (18) showed that vitamin D3
supplementation for 1 year during the sequelar stage of burn
injury was safe and efficiently corrected hypovitaminosis D.
When combined with calcium, vitamin D supplementation
demonstrated positive effects on muscle health, but not on
bone health. During the acute phase of burn injury, Rosseau
et al. supplemented 20 burn patients and 29 healthy subjects
with a single dose of 100,000 IU vitamin D3. The efficacy of
this supplementation in raising 25(OH)D levels (and free
25(OH)D levels) was reduced or even zero in the burn
patients compared to the healthy subjects. In addition, only
two burn patients achieved a 30 ng/ml serum level of 25-OH
vitamin D (19).
These contradictory results could be explained by previous
vitamin D status, interference due to increases in serum
levels of 25-OH vitamin D induced by an acute inflammatory
response, and vitamin D-binding protein and VDR poly-
morphisms. Single nucleotide polymorphisms, such as the
Taql and Bsml polymorphisms, are the most common type of
genetic variation, and they could explain the differences in
responses to vitamin D supplementation. However, in this
study, the Taql and Bsml VDR gene polymorphisms were not
associated with the hospital mortality of burn patients.
Some limitations of this study should be considered. First,
we only included patients from a single medical center.
Second, our sample size was relatively small. Third, other
polymorphisms in the VRD gene that could influence its
activity were not evaluated in this research. Additional
studies on VDR polymorphisms and vitamin D supplemen-
tation should be performed in the future to better elucidate
this issue.
In conclusion, our results suggest that the Taql and Bsml
VDR gene polymorphisms are not associated with the
hospital mortality of burn patients.
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Table 2 - Logistic regression models for prediction of mortality
of burn patients.
Variables Odds ratio 95%CI p-value
Bsml (GA+AA) 1.858 0.551-6.270 0.318
Taql (TC+CC) 2.775 0.777-9.905 0.116
Bsml (GA+AA)* 1.309 0.128-13.430 0.821
Taql (TC+CC)* 1.575 0.148-16.745 0.706
*Adjusted by age, gender and total body surface area burn
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